SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Hales RE, Yudofsky SC, Talbott JA. Textbook of Psychiatry, 3rd edn. American Psychiatric Press, Washington, DC, 1999.
  • 2
    Akiskal HS. The bipolar spectrum: research and clinical perspectives. Encephale 1995; 21: 311.
  • 3
    Szadoczky E, Papp Z, Vitrai J, Rihmer Z, Furedi J. The prevalence of major depressive and bipolar disorders in Hungary. Results from a national epidemiologic survey. J. Affect. Disord. 1998; 50: 153162.
  • 4
    Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34–38 years. J. Affect. Disord. 2002; 68: 167181.
  • 5
    Kronfol Z, Hamdan-Allen G, Black DW. Fever and leukocytosis: physical manifestations of bipolar affective disorder? Prog. Neuropsychopharmacol. Biol. Psychiatry 1988; 12: 887891.
  • 6
    Lazarus JH, McGregor AM, Ludgate M, Darke C, Creagh FM, Kingswood CJ. Effect of lithium carbonate therapy on thyroid immune status in manic depressive patients: a prospective study. J. Affect. Disord. 1986; 11: 155160.
  • 7
    Haggerty JJ, Evans DL, Golden RN, Pedersen CA, Simon JS, Nemeroff CB. The presence of antithyroid antibodies in patients with affective and non-affective psychiatric disorders. Biol. Psychiatry 1990; 27: 5160.
  • 8
    Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J. Psychiatr. Res. 1995; 29: 141152.
  • 9
    Tsai SY, Chen KP, Yang YY et al. Activation of indices of cell-mediated immunity in bipolar mania. Biol. Psychiatry 1999; 45: 989994.
  • 10
    Sadock BJ, Sadock VA. Comprehensive Textbook of Psychiatry, 7th edn. Lippincott Wiliams & Wilkins, New York, 2000; 13081309.
  • 11
    Roitt I, Brostoff J, Male D. Immunology, 6th edn. Mosby, New York, 2001.
  • 12
    Tivol EA, Schweitzer AN, Sharpe AH. Costimulation and autoimmunity. Curr. Opin. Immunol. 1996; 8: 822830.
  • 13
    Thompson CB, Allison JP. The emerging role of CTLA-4 as an immune attenuator. Immunity 1997; 7: 445450.
  • 14
    McCoy KD, Le Gros G. The role of CTLA-4 in the regulation of T cell immune responses. Immunol. Cell Biol. 1999; 77: 110.
  • 15
    Dariavach P, Mattei MG, Golstein P, Lefranc MP. Human Ig superfamily CTLA-4 gene. Chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur. J. Immunol. 1988; 18: 19011905.
  • 16
    Harper K, Balzano C, Rouvier E, Mattei MG, Luciani MF, Golstein P. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J. Immunol. 1991; 147: 10371044.
  • 17
    Linsley PS, Nadler SG, Bajorath J et al. Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4 (CTLA-4). A disulfide-linked homodimer binds two CD86 molecules. J. Biol. Chem. 1995; 270: 15 417–15 424.
  • 18
    Pullmann R Jr, , Lukac J, Skerenova M et al. Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus. Clin. Exp. Rheumatol. 1999; 17: 725729.
  • 19
    Ahmed S, Ihara K, Kanemitsu S et al. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Rheumatology 2001; 40: 662667.
  • 20
    Yanagawa T, Taniyama M, Enomoto S et al. CTLA4 gene polymorphism confers susceptibility to Graves’ disease in Japanese. Thyroid 1997; 7: 843846.
  • 21
    Krokowski M, Bodalski J, Bratek A, Machejko P, Caillat-Zucman S. CTLA-4 gene polymorphism is associated with predisposition to IDDM in a population from central Poland. Diabetes Metab. 1998; 24: 241243.
  • 22
    Nistico L, Buzzetti R, Pritchard LE et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum. Mol. Genet. 1996; 5: 10751080.
  • 23
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC, 1994.
  • 24
    Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated acid. Nucleic Acids Res. 1988; 16: 1215.
  • 25
    Jun TY, Pae CU, Chae JH, Bahk WM, Kim KS, Han H. Polymorphism of CTLA-4 gene at position 49 of exon 1 may be associated with schizophrenia in the Korean population. Psychiatry Res. 2002; 110: 1925.
  • 26
    Jun TY, Pae CU, Chae JH, Bahk WM, Kim KS. Polymorphism of CTLA-4 gene for major depression in the Korean population. Psychiatry Clin. Neurosci. 2001; 55: 533537.
  • 27
    Rapaport MH. Immune parameters in euthymic bipolar patients and normal volunteers. J. Affect. Disord. 1994; 32: 149156.
  • 28
    Su KP, Leu SJ, Yang YY, Shen WW, Chou YM, Tsai SY. Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission. J. Affect. Disord. 2002; 71: 205209.
  • 29
    Kronfol Z, House JD. Immune function in mania. Biol. Psychiatry., 1988; 24: 341343.